NYLI MacKay DefinedTerm Muni Opportunities Fund declares $0.06 dividend
[ad_1]
NYLI MacKay DefinedTerm Muni Opportunities Fund declares $0.06 dividend
[ad_2]
Similar Posts
Agios' supplemental new drug application for its thalassemia treatment gets FDA nod
Byadmin
[ad_1] Agios' supplemental new drug application for its thalassemia treatment gets FDA nod [ad_2]
EVgo expects to triple its charging network by 2029 with help from DofE and General Motors
Byadmin
[ad_1] EVgo expects to triple its charging network by 2029 with help from DofE and General Motors [ad_2]
Macy's to close 66 under-performing stores across U.S.
Byadmin
[ad_1] Macy's to close 66 under-performing stores across U.S. [ad_2]
Alaska Air Group Flight Attendants Set to Receive 32% Pay Increase in Record Contract
Byadmin
[ad_1] PRWire: Alaska Air Group Inc. is making headlines with a groundbreaking agreement set to increase unionized flight attendants’ pay by an average of 32%. This substantial pay raise is part of a new “record contract” announced by the Association of Flight Attendants Alaska late Tuesday, highlighting a series of improved remuneration and conditions, including…
Here's the major earnings before the open tomorrow
Byadmin
[ad_1] Here's the major earnings before the open tomorrow [ad_2]
REGENXBIO partners with Nippon Shinyaku for MPS therapies
Byadmin
[ad_1] YinYang REGENXBIO (NASDAQ:RGNX) and Nippon Shinyaku have entered into a partnership for the development and commercialization of REGENXBIO’s gene therapies RGX-121 for the treatment of Hunter syndrome, or MPS II, and RGX-111 for Hurler syndrome, or MPS I. Under the deal, REGENXBIO ( [ad_2]